Founded in 1999, the New York-based firm focuses on acyclical growth industries and emphasizes growth and business building in its investments, rather than high risk or debt leverage. Its public equity arm, Vantage, applies the firm's research and business building strengths towards non-control positions in publicly traded companies. New Mountain oversees approximately $15.0 billion of capital across four private equity funds plus Vantage and NMFC. The firm's investment efforts are concentrated on carefully selected "defensive growth" niches, such as healthcare, health tech, life science supplies/biomanufacturing, information and data, digital marketing & transformation, infrastructure services/field services, specialized software, defensive growth consumer/products, financial services/technologies, and technology-enabled business services. The firm has developed particular research and operational expertise in these sectors and works systematically to establish expertise in additional sectors over time.